Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2018 (2018), Article ID 8672407, 5 pages
https://doi.org/10.1155/2018/8672407
Case Report

Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review

1Chair and Department of Oncology, Medical University of Lublin, Lublin, Poland
2Radiation Therapy Department, Lublin Oncological Center, Lublin, Poland
3Chair and Department of Clinical Pathomorphology, Medical University of Lublin, Lublin, Poland
41st Gynecological Oncology and Gynecology Clinic, Independent Public Clinical Hospital No. 1 in Lublin, Lublin, Poland
5Brachytherapy Department, Lublin Oncological Center, Lublin, Poland
6Radiotherapy Department, Lublin Oncological Center, Lublin, Poland

Correspondence should be addressed to M. Bilski; moc.liamg@tamikslib

Received 31 July 2017; Revised 28 November 2017; Accepted 18 January 2018; Published 11 February 2018

Academic Editor: Peter F. Lenehan

Copyright © 2018 M. Bilski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Spleen sarcoma is one of the most rare soft tissue malignancies. The annual incidence is 0.14–0.25/1,000,000 and the average age of diagnosis is 50 to 73 years. The incidence of this cancer has been increasing. Treatment of choice is surgical splenectomy, which rarely gives good results due to the aggressive course of the disease as well as the high potential for metastasis. Overall survival in primary spleen sarcomas as described by various authors is between 4 and 14 months. 80% of patients after spleen rupture do not survive 6 months. We report the case of a 42-year-old male diagnosed with spleen angiosarcoma. The patient underwent surgery in an emergency mode because of rapid rupture of the organ. Due to positive surgical margins, he underwent adjuvant radiochemotherapy followed by chemotherapy. Overall survival time was relatively long (23 months). The international guidelines provide information based on limited data. The role of postoperative radiotherapy in angiosarcomas remains controversial. Postoperative radiotherapy may increase local disease control, especially after nonradical operation, but this does not translate into improvement in overall survival time of these patients. The case shows that adjuvant radiotherapy as part of cancer treatment strategy may prolong the overall survival.